Skip to main content
Top
Published in: Rheumatology International 6/2015

01-06-2015 | Short Communication - Cases with a Message

What type of different clinical manifestations can cardiac sarcoidosis present?

Authors: Ayşegül Şentürk, Yüksel Maraş, Emine Argüder, Ayşegül Karalezli, H. Canan Hasanoğlu, Tuba Öğüt, Serdal Baştuğ, Ercan Karabekir

Published in: Rheumatology International | Issue 6/2015

Login to get access

Abstract

Cardiac sarcoidosis is an infiltrative, granulomatous inflammatory disease of the myocardium. Generally, it can be difficult to diagnose cardiac sarcoidosis clinically because of the non-specific nature of its clinical manifestations. This property can be based on the presence of any clinical evidence of sarcoidosis in the other organs. We present two cases of cardiac sarcoidosis so as to demonstrate its different clinical manifestations. The first patient displayed no cardiac symptoms; the electrocardiogram showed an incidental right bundle branch block. Her cardiac magnetic resonance imaging (CMRI) revealed late-phase opaque material enhancement involving the inferior and inferoseptal segment of the left ventricle. The second patient was severely symptomatic in terms of cardiac involvement, and a transthoracic echocardiogram revealed global hypokinesia and septal brightness; his ejection fraction decreased to 45 %. These cases highlighted the challenges encountered in the diagnosis and treatment of cardiac sarcoidosis. CMRI should be considered in all patients who have suspected findings for cardiac involvement.
Literature
2.
go back to reference Ekka M, Sinha S, Purushothaman R et al (2013) Ventricular tachycardia—an atypical initial presentation of sarcoidosis: a case report. J Med Case Rep 7:196–201CrossRefPubMedCentralPubMed Ekka M, Sinha S, Purushothaman R et al (2013) Ventricular tachycardia—an atypical initial presentation of sarcoidosis: a case report. J Med Case Rep 7:196–201CrossRefPubMedCentralPubMed
3.
go back to reference Iwai K, Sekiguti M, Hosoda Y et al (1994) Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 11:26–31PubMed Iwai K, Sekiguti M, Hosoda Y et al (1994) Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 11:26–31PubMed
4.
go back to reference Nery PB, Leung E, Birnie DH (2012) Arrhythmias in cardiac sarcoidosis: diagnosis and treatment. Curr Opin Cardiol 27:181–189CrossRefPubMed Nery PB, Leung E, Birnie DH (2012) Arrhythmias in cardiac sarcoidosis: diagnosis and treatment. Curr Opin Cardiol 27:181–189CrossRefPubMed
5.
go back to reference Soejima K, Yada H (2009) The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities. J Cardiovasc Electrophysiol 20:578–583CrossRefPubMed Soejima K, Yada H (2009) The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities. J Cardiovasc Electrophysiol 20:578–583CrossRefPubMed
7.
go back to reference Bhargava K (2012) Cardiac sarcoidosis—arrhythmias, inflammation and anti-inflammatory drug therapy. Indian Pacing Electrophysiol J 12:234–236PubMedCentralPubMed Bhargava K (2012) Cardiac sarcoidosis—arrhythmias, inflammation and anti-inflammatory drug therapy. Indian Pacing Electrophysiol J 12:234–236PubMedCentralPubMed
8.
go back to reference Hiraga H, Hiroe M, Iwai K (1993) Guideline for diagnosis of cardiac sarcoidosis: study report on diffuse pulmonary diseases. The Japanese Ministry of Health and Welfare, Tokyo, pp 23–24 (in Japanese) Hiraga H, Hiroe M, Iwai K (1993) Guideline for diagnosis of cardiac sarcoidosis: study report on diffuse pulmonary diseases. The Japanese Ministry of Health and Welfare, Tokyo, pp 23–24 (in Japanese)
9.
go back to reference Burstow DJ, Tajik AJ, Bailey KR et al (1989) Two-dimensional echocardiographic findings in systemic sarcoidosis. Am J Cardiol 63:478–482CrossRefPubMed Burstow DJ, Tajik AJ, Bailey KR et al (1989) Two-dimensional echocardiographic findings in systemic sarcoidosis. Am J Cardiol 63:478–482CrossRefPubMed
10.
go back to reference Ohira H, Tsujino I, Ishimaru S et al (2008) Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging 35:933–941CrossRefPubMed Ohira H, Tsujino I, Ishimaru S et al (2008) Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging 35:933–941CrossRefPubMed
11.
go back to reference White J, Sutton T, Kerr A (2010) Isolated primary cardiac sarcoidosis: MRI diagnosis and monitoring of treatment response with cardiac enzyme. Circ Heart Fail 3:e28–e29CrossRefPubMed White J, Sutton T, Kerr A (2010) Isolated primary cardiac sarcoidosis: MRI diagnosis and monitoring of treatment response with cardiac enzyme. Circ Heart Fail 3:e28–e29CrossRefPubMed
12.
go back to reference Kandolin R, Lehtonen J, Graner M et al (2011) Diagnosing isolated cardiac sarcoidosis. J Intern Med 270:461–468CrossRefPubMed Kandolin R, Lehtonen J, Graner M et al (2011) Diagnosing isolated cardiac sarcoidosis. J Intern Med 270:461–468CrossRefPubMed
13.
14.
go back to reference Sugizaki Y, Tanaka H, Imanishi J et al (2013) Isolated primary cardiac sarcoidosis presenting as acute heart failure. Intern Med 52:71–74CrossRefPubMed Sugizaki Y, Tanaka H, Imanishi J et al (2013) Isolated primary cardiac sarcoidosis presenting as acute heart failure. Intern Med 52:71–74CrossRefPubMed
15.
16.
go back to reference Yazaki Y, Isobe M, Hiroe M et al (2001) Central Japan Heart Study Group. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 88:1006–1010CrossRefPubMed Yazaki Y, Isobe M, Hiroe M et al (2001) Central Japan Heart Study Group. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 88:1006–1010CrossRefPubMed
18.
go back to reference Koplan BA, Soejima K, Baughman K et al (2006) Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation. Heart Rhythm 3:924–929CrossRefPubMed Koplan BA, Soejima K, Baughman K et al (2006) Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation. Heart Rhythm 3:924–929CrossRefPubMed
19.
go back to reference Brown AJ, McCormick LM, Agrawal SK, De Bono J (2012) A dramatic presentation of cardiac sarcoidosis. QJM 105:269–271CrossRefPubMed Brown AJ, McCormick LM, Agrawal SK, De Bono J (2012) A dramatic presentation of cardiac sarcoidosis. QJM 105:269–271CrossRefPubMed
20.
go back to reference Kandolin R, Lehtonen J, Kupari M (2011) Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults. Circ Arrhythm Electrophysiol 4:303–309CrossRefPubMed Kandolin R, Lehtonen J, Kupari M (2011) Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults. Circ Arrhythm Electrophysiol 4:303–309CrossRefPubMed
22.
go back to reference Chiu CZ, Nakatani S, Zhang G et al (2005) Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis. Am J Cardiol 95:143–146CrossRefPubMed Chiu CZ, Nakatani S, Zhang G et al (2005) Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis. Am J Cardiol 95:143–146CrossRefPubMed
Metadata
Title
What type of different clinical manifestations can cardiac sarcoidosis present?
Authors
Ayşegül Şentürk
Yüksel Maraş
Emine Argüder
Ayşegül Karalezli
H. Canan Hasanoğlu
Tuba Öğüt
Serdal Baştuğ
Ercan Karabekir
Publication date
01-06-2015
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 6/2015
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-014-3183-z

Other articles of this Issue 6/2015

Rheumatology International 6/2015 Go to the issue

Letter to the Editor - Cases with a Message

Ankle pain in hereditary multiple exostoses: a case report

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine